Validity and Reliability of the 6-minute Stepper Test in Patients With Peripheral Artery Disease
Examination of the Validity and Reliability of 6-minute Stepper Test in Patients With Peripheral Artery Disease
Gazi University
24 participants
Sep 24, 2025
OBSERVATIONAL
Conditions
Summary
Hemodynamic dysfunction and decreased blood flow to the extremities negatively affect patients' muscle oxygenation, balance, claudication pain, lower extremity muscle strength, and arterial stiffness. These negatively affect patients' exercise capacity. The six-minute stepper test (6 MST) is a simple, low-cost, and minimal space requirement assessment method used to evaluate functional exercise capacity and is known to be valid and reliable for various pulmonary and cardiovascular diseases. However, it is not known whether the 6 MST is valid and reliable in assessing functional exercise capacity in patients with PAD. It is known that muscle oxygen levels, balance levels, intermittent claudication, lower extremity muscle strength, and arterial stiffness have negative effects on exercise capacity. However, the extent to which these variables affect the 6 MST is unknown. The primary aim is to examine the validity and reliability of the 6 MST in patients with PAD. The secondary aim is to evaluate arterial stiffness, muscle oxygen levels, intermittent claudication, static and dynamic balance levels, lower extremity muscle strength, and examine their effects on the 6 MST.
Eligibility
Inclusion Criteria5
- Diagnosed with peripheral artery disease by the Department of Cardiovascular Surgery,
- Ankle-brachial index (ABI) ≤1.40 or exercise ABI ≤0.73 or diagnosed with calcified vascular response, in remission and under follow-up,
- Stable,
- Ages between 18 and 80,
- Patients who volunteer to participate in the study will be included.
Exclusion Criteria10
- Patients will be excluded if they have:
- Previously underwent ischaemic amputation,
- Unstable coronary artery disease,
- Uncontrolled Diabetes Mellitus,
- Pulmonary disease,
- Acute infection,
- Weight \>110 kg because it is the upper limit of the stepper device,
- Contraindications to exercise testing per the American Sports Medicine Association,
- Pregnant and breastfeeding women,
- Patients with PAD who have undergone major surgery or had a myocardial infarction within the last 3 months.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07169045